Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis
Drug-induced liver injury (DILI) is a disease that remains difficult to predict and prevent from a clinical perspective, as its occurrence is hard to fully explain by the traditional mechanisms. In recent years, the risk of the DILI for microbiota dysbiosis has been recognized as a multifactorial pr...
Main Authors: | Lihong Fu, Yihan Qian, Zhi Shang, Xuehua Sun, Xiaoni Kong, Yueqiu Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.972518/full |
Similar Items
-
Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
by: Gaby Danan, et al.
Published: (2019-07-01) -
Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method
by: Ling Ye, et al.
Published: (2021-12-01) -
Gut microbiota and mechanism of liver cancer
by: CHEN Congyan, WANG Junqing, CHEN Yongjun
Published: (2022-06-01) -
Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
by: Takashi Kobayashi, et al.
Published: (2022-10-01) -
Hepatic DNA Methylation in Response to Early Stimulation of Microbiota with <i>Lactobacillus</i> Synbiotics in Broiler Chickens
by: Aleksandra Dunislawska, et al.
Published: (2020-05-01)